Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Flynn

Showing results (601-610 of 644) with videos related to

Pageof 65
Sort By:
ACS Central Science|December 5, 2017
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor CytotoxicityFrederick M Tomlin, Ulla I M Gerling-Driessen, Yi-Chang Liu, et al.
Science Translational Medicine|December 1, 2021
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type CJohn V Pluvinage, Jerry Sun, Christel Claes, et al.
British Journal of Haematology|November 18, 2020
Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinibJorge J Castillo, Jithma P Abeykoon, Joshua N Gustine, et al.
Leukemia|September 17, 2021
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemiaJorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.
Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
Elife|January 11, 2019
The novel lncRNA <i>lnc-NR2F1</i> is pro-neurogenic and mutated in human neurodevelopmental disordersCheen Euong Ang, Qing Ma, Orly L Wapinski, et al.
Nature Methods|May 29, 2019
HiChIRP reveals RNA-associated chromosome conformationMaxwell R Mumbach, Jeffrey M Granja, Ryan A Flynn, et al.
Journal of Medicinal Chemistry|December 4, 2010
Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agentRupa S Shetty, Younghee Lee, Bin Liu, et al.
Nature|July 6, 2018
Retraction Note: DDX5 and its associated lncRNA Rmrp modulate T<sub>H</sub>17 cell effector functionsWendy Huang, Benjamin Thomas, Ryan A Flynn, et al.
Nature|August 6, 2025
RNA N-glycosylation enables immune evasion and homeostatic efferocytosisVincent R Graziano, Jennifer Porat, Marie Dominique Ah Kioon, et al.
Pageof 65

Showing results (601-610 of 644) with videos related to

Sort By:
Pageof 65
ACS Central Science|December 5, 2017
Inhibition of NGLY1 Inactivates the Transcription Factor Nrf1 and Potentiates Proteasome Inhibitor CytotoxicityFrederick M Tomlin, Ulla I M Gerling-Driessen, Yi-Chang Liu, et al.
Science Translational Medicine|December 1, 2021
The CD22-IGF2R interaction is a therapeutic target for microglial lysosome dysfunction in Niemann-Pick type CJohn V Pluvinage, Jerry Sun, Christel Claes, et al.
British Journal of Haematology|November 18, 2020
Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinibJorge J Castillo, Jithma P Abeykoon, Joshua N Gustine, et al.
Leukemia|September 17, 2021
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemiaJorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.
Kidney International|December 24, 2010
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of lifeDebbie S Gipson, Howard Trachtman, Frederick J Kaskel, et al.
Elife|January 11, 2019
The novel lncRNA <i>lnc-NR2F1</i> is pro-neurogenic and mutated in human neurodevelopmental disordersCheen Euong Ang, Qing Ma, Orly L Wapinski, et al.
Nature Methods|May 29, 2019
HiChIRP reveals RNA-associated chromosome conformationMaxwell R Mumbach, Jeffrey M Granja, Ryan A Flynn, et al.
Journal of Medicinal Chemistry|December 4, 2010
Synthesis and pharmacological evaluation of N-(3-(1H-indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a potent antimitotic agentRupa S Shetty, Younghee Lee, Bin Liu, et al.
Nature|July 6, 2018
Retraction Note: DDX5 and its associated lncRNA Rmrp modulate T<sub>H</sub>17 cell effector functionsWendy Huang, Benjamin Thomas, Ryan A Flynn, et al.
Nature|August 6, 2025
RNA N-glycosylation enables immune evasion and homeostatic efferocytosisVincent R Graziano, Jennifer Porat, Marie Dominique Ah Kioon, et al.
Pageof 65